Molecular mechanisms of regulated necrosis - PubMed (original) (raw)
Review
Molecular mechanisms of regulated necrosis
Lorenzo Galluzzi et al. Semin Cell Dev Biol. 2014 Nov.
Abstract
It is now clear that apoptosis does not constitute the sole genetically encoded form of cell death. Rather, cells can spontaneously undertake or exogenously be driven into a cell death subroutine that manifests with necrotic features, yet can be inhibited by pharmacological and genetic interventions. As regulated necrosis (RN) plays a major role in both physiological scenarios (e.g., embryonic development) and pathological settings (e.g., ischemic disorders), consistent efforts have been made throughout the last decade toward the characterization of the molecular mechanisms that underlie this cell death modality. Contrarily to initial beliefs, RN does not invariably result from the activation of a receptor interacting protein kinase 3 (RIPK3)-dependent signaling pathway, but may be ignited by distinct molecular networks. Nowadays, various types of RN have been characterized, including (but not limited to) necroptosis, mitochondrial permeability transition (MPT)-dependent RN and parthanatos. Of note, the inhibition of only one of these modules generally exerts limited cytoprotective effects in vivo, underscoring the degree of interconnectivity that characterizes RN. Here, we review the signaling pathways, pathophysiological relevance and therapeutic implications of the major molecular cascades that underlie RN.
Keywords: AIF; Entosis; Ferroptosis; Mitochondrial membrane permeabilization; Pyroptosis; RIPK3.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
- Nonapoptotic cell death in acute kidney injury and transplantation.
Linkermann A. Linkermann A. Kidney Int. 2016 Jan;89(1):46-57. doi: 10.1016/j.kint.2015.10.008. Kidney Int. 2016. PMID: 26759047 Review. - Necroptotic Cell Death Signaling and Execution Pathway: Lessons from Knockout Mice.
Belizário J, Vieira-Cordeiro L, Enns S. Belizário J, et al. Mediators Inflamm. 2015;2015:128076. doi: 10.1155/2015/128076. Epub 2015 Sep 27. Mediators Inflamm. 2015. PMID: 26491219 Free PMC article. Review. - Programmed necrosis and necroptosis signalling.
Feoktistova M, Leverkus M. Feoktistova M, et al. FEBS J. 2015 Jan;282(1):19-31. doi: 10.1111/febs.13120. Epub 2014 Nov 11. FEBS J. 2015. PMID: 25327580 Review. - Necroptosis, in vivo detection in experimental disease models.
Jouan-Lanhouet S, Riquet F, Duprez L, Vanden Berghe T, Takahashi N, Vandenabeele P. Jouan-Lanhouet S, et al. Semin Cell Dev Biol. 2014 Nov;35:2-13. doi: 10.1016/j.semcdb.2014.08.010. Epub 2014 Aug 23. Semin Cell Dev Biol. 2014. PMID: 25160988 Review. - Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.
Newton K, Dugger DL, Wickliffe KE, Kapoor N, de Almagro MC, Vucic D, Komuves L, Ferrando RE, French DM, Webster J, Roose-Girma M, Warming S, Dixit VM. Newton K, et al. Science. 2014 Mar 21;343(6177):1357-60. doi: 10.1126/science.1249361. Epub 2014 Feb 20. Science. 2014. PMID: 24557836
Cited by
- p38MAPK guards the integrity of endosomal compartments through regulating necrotic death.
Yao J, Atasheva S, Toy R, Blanchard EL, Santangelo PJ, Roy K, Mocarski ES, Shayakhmetov DM. Yao J, et al. Sci Rep. 2022 Sep 29;12(1):16357. doi: 10.1038/s41598-022-20786-4. Sci Rep. 2022. PMID: 36175595 Free PMC article. - Programmed cell death, from liver Ischemia-Reperfusion injury perspective: An overview.
Luo S, Luo R, Deng G, Huang F, Lei Z. Luo S, et al. Heliyon. 2024 Jun 17;10(13):e32480. doi: 10.1016/j.heliyon.2024.e32480. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39040334 Free PMC article. Review. - Programmed Cell Death in Sepsis Associated Acute Kidney Injury.
Wu Z, Deng J, Zhou H, Tan W, Lin L, Yang J. Wu Z, et al. Front Med (Lausanne). 2022 May 17;9:883028. doi: 10.3389/fmed.2022.883028. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35655858 Free PMC article. Review. - Non-Coding RNAs and Oral Cancer: Small Molecules With Big Functions.
Erfanparast L, Taghizadieh M, Shekarchi AA. Erfanparast L, et al. Front Oncol. 2022 Jul 11;12:914593. doi: 10.3389/fonc.2022.914593. eCollection 2022. Front Oncol. 2022. PMID: 35898889 Free PMC article. Review. - Targeting Drug Chemo-Resistance in Cancer Using Natural Products.
Talib WH, Alsayed AR, Barakat M, Abu-Taha MI, Mahmod AI. Talib WH, et al. Biomedicines. 2021 Sep 29;9(10):1353. doi: 10.3390/biomedicines9101353. Biomedicines. 2021. PMID: 34680470 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous